BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE
Patent Owner
Stats
- 21 US PATENTS IN FORCE
- 7 US APPLICATIONS PENDING
- Dec 05, 2017 most recent publication
Details
- 21 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 364 Total Citation Count
- Feb 27, 2002 Earliest Filing
- 23 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2016/0025,704 METHODS FOR IDENTIFYING NEUROPROTECTIVE PKC ACTIVATORSMar 15, 14Jan 28, 16[C12Q, G01N]
2014/0329,264 FIBROBLAST GROWTH PATTERNS FOR DIAGNOSIS OF ALZHEIMER'S DISEASEFeb 10, 14Nov 06, 14[G01N]
2014/0235,496 STIMULUS-ELICITED GENOMIC PROFILE MARKERS OF A NEURODEGENERATIVE CONDITIONOct 05, 12Aug 21, 14[C12Q, G01N]
2014/0038,186 ALZHEIMER'S DISEASE-SPECIFIC ALTERATIONS OF PROTEIN KINASE C EPSILON (PKC-EPSILON) PROTEIN LEVELSFeb 22, 11Feb 06, 14[C12Q, G01N]
2013/0165,453 THERAPEUTIC EFFECTS OF BRYOSTATINS, BRYOLOGS, AND OTHER RELATED SUBSTANCES ON ISCHEMIA/STROKE-INDUCED MEMORY IMPAIRMENT AND BRAIN INJURYJul 19, 12Jun 27, 13[A61K]
2011/0245,307 Methods for Alzheimer's Disease Treatment and Cognitive EnhancementMar 08, 11Oct 06, 11[A61K, C12N, A61P]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9597312 Treatment of cognitive disorders associated with abnormal dendritic spines using PKC activatorsAug 19, 11Mar 21, 17[A61K]
9446020 Methods for Alzheimer'S disease treatment and cognitive enhancementNov 02, 15Sep 20, 16[A61K]
9345685 Methods for Alzheimer's Disease treatment and cognitive enhancementSep 16, 10May 24, 16[A61K]
9163032 Esters of DCPLA and methods of treatment using the sameNov 13, 12Oct 20, 15[A61K, C07D, C07C, C07J]
9119825 PKC-activating compounds for the treatment of neurodegenerative diseasesFeb 21, 12Sep 01, 15[A61K]
9066923 Methods for Alzheimer's disease treatment and cognitive enhancementAug 10, 09Jun 30, 15[A61K]
8703812 Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learningJul 30, 12Apr 22, 14[A61K, A01N]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0249,176 PROTEIN SYNTHESIS REQUIRED FOR LONG-TERM MEMORY IS INDUCED BY PKC ACTIVATION ON DAYS PRECEDING ASSOCIATIVE LEARNINGAbandonedMar 04, 14Sep 04, 14[A61K]
2013/0331,427 METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC, REMODELING AND CONSOLIDATION OF LONG-TERM MEMORYAbandonedOct 25, 12Dec 12, 13[A61K]
2013/0231,384 METHODS OF STIMULATING CELLULAR GROWTH, SYNAPTIC REMODELING AND CONSOLIDATION OF LONG-TERM MEMORYAbandonedSep 27, 12Sep 05, 13[A61K]
2013/0072,550 PKC ACTIVATION AS A MEANS FOR ENHANCING sAPPalpha SECRETION AND IMROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDSAbandonedSep 10, 12Mar 21, 13[A61K, A61P]
2011/0212,474 ABNORMAL ALTERATIONS OF PKC ISOZYMES PROCESSING IN ALZHEIMER'S DISEASE PERIPHERAL CELLSAbandonedOct 01, 10Sep 01, 11[C12Q]
2011/0196,028 PCK ACTIVATION AS A MEANS FOR ENHANCING sAPPa SECRETION AND IMPROVING COGNITION USING BRYOSTATIN TYPE COMPOUNDSAbandonedJun 17, 10Aug 11, 11[A61K, A61P]
2010/0303,792 PROTEIN SYNTHESIS REQUIRED FOR LONG-TERM MEMORY IS INDUCED BY PKC ACTIVATION ON DAYS PRECEDING ASSOCIATIVE LEARNINGAbandonedAug 05, 10Dec 02, 10[A61K, A61P]
2009/0036,514 Therapeutic effects of Bryostatins, Bryologs, and other related substances on Ischemia/stroke-induced memory impairment and brain injuryAbandonedFeb 11, 08Feb 05, 09[A61K, A61P]
2009/0029,355 Abnormalities of Phosphatase 2A (PP2A) for Diagnosis and Treatment of Alzheimer's DiseaseAbandonedNov 15, 04Jan 29, 09[C12Q, G01N, C07K]
2009/0029,873 Alzheimer's Disease-Specific Alterations of the Erk1/Erk2 Phosphorylation Ratio-Alzheimer's Disease-Specific Molecular Biomarkers (Adsmb)AbandonedSep 25, 06Jan 29, 09[C12Q, G01N, C40B]
2009/0030,055 PKC activation as a means for enhancing sAPPALPHA secretion and improving cognition using bryostatin type compoundsAbandonedMay 24, 07Jan 29, 09[A61K, C12N]
2008/0221,042 Alzheimer's disease-specific alterations of the ERK1/ERK2 Phosphorylation ratio-Alzheimer's disease-specific molecular biomarkers (ADSMB)AbandonedApr 07, 08Sep 11, 08[A61K, C12Q, A61P]
2008/0025,961 Methods of stimulating cellular growth, synaptic remodeling and consolidation of long-term memoryAbandonedJan 29, 07Jan 31, 08[A61K, C12N, A61P]
2007/0054,890 Protein synthesis required for long-term memory is induced by PKC activation on days preceding associative learningAbandonedJul 28, 06Mar 08, 07[A61K]
2007/0037,871 Pkc activation as a means for enhancing sappalpha secretion and improving cognition using bryostatin type compoundsAbandonedJul 02, 03Feb 15, 07[A61K]
2006/0275,821 Method for isolating subpopulations of proteins that engage in protein-protein interactionsAbandonedAug 14, 02Dec 07, 06[G01N, C07K]
2005/0065,205 Methods for Alzheimer's disease treatment and cognitive enhanceAbandonedSep 10, 04Mar 24, 05[A61K]
2004/0248,909 Adenosine a1 receptor antagonist for treating hypoxia-induced learning memory impairmentAbandonedJun 25, 04Dec 09, 04[A61K]
2004/0235,889 Carbonic anhydrase activator for enhancing learning and memoryAbandonedJun 22, 04Nov 25, 04[A01N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.